Targeted inhibition of the epidermal gro
β
Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie
π
Article
π
2004
π
John Wiley and Sons
π
English
β 297 KB
π 2 views
## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (βIressaβ), an orally a